Suppr超能文献

电纺 Janus 串珠结构用于实现两种药物的不同类型控制释放。

Electrospun Janus Beads-On-A-String Structures for Different Types of Controlled Release Profiles of Double Drugs.

机构信息

School of Materials Science and Engineering, University of Shanghai for Science and Technology, Shanghai 200093, China.

Shanghai Engineering Technology Research Center for High-Performance Medical Device Materials, Shanghai 200093, China.

出版信息

Biomolecules. 2021 Apr 25;11(5):635. doi: 10.3390/biom11050635.

Abstract

A side-by-side electrospinning process characterized by a home-made eccentric spinneret was established to produce the Janus beads-on-a-string products. In this study, ketoprofen (KET) and methylene blue (MB) were used as model drugs, which loaded in Janus beads-on-a-string products, in which polyvinylpyrrolidone K90 (PVP K90) and ethyl cellulose (EC) were exploited as the polymer matrices. From SEM images, distinct nanofibers and microparticles in the Janus beads-on-a-string structures could be observed clearly. X-ray diffraction demonstrated that all crystalline drugs loaded in Janus beads-on-a-string products were transferred into the amorphous state. ATR-FTIR revealed that the components of prepared Janus nanostructures were compatibility. In vitro dissolution tests showed that Janus beads-on-a-string products could provide typical double drugs controlled-release profiles, which provided a faster immediate release of MB and a slower sustained release of KET than the electrospun Janus nanofibers. Drug releases from the Janus beads-on-a-string products were controlled through a combination of erosion mechanism (linear MB-PVP sides) and a typical Fickian diffusion mechanism (bead KET-EC sides). This work developed a brand-new approach for the preparation of the Janus beads-on-a-string nanostructures using side-by-side electrospinning, and also provided a fresh idea for double drugs controlled release and the potential combined therapy.

摘要

一种采用自制偏心喷丝头的并列静电纺丝工艺被建立起来,以生产Janus 串珠产品。在这项研究中,酮洛芬(KET)和亚甲蓝(MB)被用作模型药物,它们负载在 Janus 串珠产品中,其中聚乙烯吡咯烷酮 K90(PVP K90)和乙基纤维素(EC)被用作聚合物基质。从 SEM 图像中,可以清楚地观察到 Janus 串珠结构中明显的纳米纤维和微粒。X 射线衍射表明,负载在 Janus 串珠产品中的所有结晶药物都转变成非晶态。ATR-FTIR 表明制备的 Janus 纳米结构的成分具有相容性。体外溶解试验表明,Janus 串珠产品可以提供典型的双重药物控制释放曲线,与静电纺丝的 Janus 纳米纤维相比,MB 具有更快的即刻释放,而 KET 则具有更缓慢的持续释放。Janus 串珠产品中的药物释放通过侵蚀机制(线性 MB-PVP 侧)和典型的菲克扩散机制(珠状 KET-EC 侧)的组合来控制。这项工作开发了一种使用并列静电纺丝制备 Janus 串珠纳米结构的全新方法,也为双重药物控制释放和潜在的联合治疗提供了新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41c4/8146616/1d1c7acad29b/biomolecules-11-00635-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验